Diallyllysergamide
N,''N''-Diallyllysergamide, also known as lysergic acid diallylamide, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide. It is taken orally.
In his 1997 book TiHKAL, Alexander Shulgin described DAL as producing "at best a touch of sparkle" of LSD at dose of 600μg of the tartrate salt taken orally, but as also producing a sedation. Subsequently, in a 2003 literature review, Shulgin listed an active dose as greater than 1mg. He has described the drug as being at least an order of magnitude less potent than LSD.
Pharmacology
Pharmacodynamics
DAL interacts with serotonin receptors, including the serotonin 5-HT1A, 5-HT2A, and 5-HT2C receptors. It acts as a serotonin 5-HT2A receptor agonist, but with about 5-fold lower potency than LSD.